Fig. 6From: Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer(A) Overview of the experimental design of in vivo antileukemia activity (n = 5). (B) WBC counts, (C) PLT counts, (D) HGB level of peripheral blood collected from the eye socket of the AML mice on day 9. (E) ALT level in serum. (F) AST level in serum. (G) Body weight changes of mice. (H) Survival curves of miceBack to article page